🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

183+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 183 recruiting trials for “hepatocellular-carcinoma

Phase 2RecruitingNCT07072728

Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder

👨‍⚕️ Clive Ward-Able, Psyence Biomedical📍 3 sites📅 Started Oct 2025View details ↗
Phase 4RecruitingNCT07028125

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

🏥 Centre Francois Baclesse📍 10 sites📅 Started Oct 2025View details ↗
RecruitingNCT07315633

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

🏥 University Hospital, Ghent📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07145801

Y-90 Treatment Response Using Transarterial Radioembolization

👨‍⚕️ John Eisenbrey, PhD, Thomas Jefferson University📍 1 site📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT07337421

Efcacy and Safety of Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With mFOLFOX in Hepatocellular Carcinoma With High-risk Recurrence Factors

👨‍⚕️ Dou-sheng Bai, Clinical Medical College, Yangzhou University📍 1 site📅 Started Sep 2025View details ↗
Enrolling by InvitationNCT06885424

A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products

👨‍⚕️ Eric Ng, MD, A2 Biotherapeutics📍 2 sites📅 Started Aug 2025View details ↗
Phase 4RecruitingNCT07150624

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

🏥 Anhui Provincial Hospital📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07334483

A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC

👨‍⚕️ Zhiping Yan, MD, Fudan University📍 3 sites📅 Started Aug 2025View details ↗
RecruitingNCT07100405

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

🏥 Fudan University📍 1 site📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT07391839

MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.

🏥 Suzhou Mednovo Yi Medical Technology Co., Ltd.📍 8 sites📅 Started Aug 2025View details ↗
NARecruitingNCT06824974

To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients

👨‍⚕️ Nick Webster, PhD, Universoty of California San Diego📍 1 site📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT07077356

Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma

🏥 West China Hospital📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07345247

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

🏥 Ankara University📍 20 sites📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT06841172

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

👨‍⚕️ Jinbo Yue, Doctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Jul 2025View details ↗
Phase 1, PHASE2RecruitingNCT07070518

Study of GV20-0251 in Participants With Solid Tumor Malignancies

🏥 GV20 Therapeutics📍 3 sites📅 Started Jul 2025View details ↗
Phase 2RecruitingNCT07386158

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

🏥 Sun Yat-sen University📍 1 site📅 Started Jul 2025View details ↗
Phase 2Enrolling by InvitationNCT07101900

68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

🏥 Peking Union Medical College Hospital📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07039201

A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)

🏥 Zhejiang University📍 2 sites📅 Started Jun 2025View details ↗
EARLY_Phase 1RecruitingNCT07067905

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

🏥 Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT07018518

PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma

👨‍⚕️ Weidong Han, Ph.D, Biotherapeutic Department, Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
← PreviousPage 2 of 10Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →